Non-Pharmacologic Interventions for Rheumatoid Arthritis

Video Poster Save

Click to download or view mobile version

Author(s):

Abstract or description:

More Virtual Posters

UCB RNL 2026 Poster (2)

Achieving early clinical response was associated with cumulative benefits on disease impact up to 2 years in patients with active psoriatic arthritis treated with bimekizumab

Genentech RNL Poster 1

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

Genentech RNL Poster 2

Obinutuzumab Induces Histologic Remission and Deep Kidney Parenchymal B-Cell Depletion in Participants With Lupus Nephritis: Exploratory Analyses of the Phase III REGENCY Trial

Amgen Poster Submission (RNL2026)

One-year real-world effectiveness with avacopan in granulomatosis with polyangiitis and microscopic polyangiitis in a large healthcare system

ADD THE FIRST COMMENT

If you are a health practitioner, you may Login/Register to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×